PMID: 3856953Mar 1, 1985Paper

Isolation and genetic characterization of human KB cell lines resistant to multiple drugs

Somatic Cell and Molecular Genetics
S AkiyamaM M Gottesman


Human KB cell lines resistant to high levels of colchicine were isolated by several successive single-step selections. Most of these selection steps resulted in cross-resistance to vincristine, vinblastine, adriamycin, actinomycin D, and puromycin; however, at the highest levels of colchicine resistance, increased cross-resistance to other drugs was not observed. There was no major change in protein synthesis or alteration in protein phosphorylation or [14C]glucosamine labeling patterns accompanying the development of multiple drug resistance as measured by analysis of metabolically labeled proteins on SDS gels. Cell-cell hybridization experiments showed that the colchicine-resistant and multiple drug-resistant phenotypes were incompletely dominant. In addition, colchicine resistance was found to segregate independently from resistance to other drugs in one somatic cell hybrid, suggesting that complex genetic loci are involved in the development of the multiple drug-resistant phenotype. These mutants should be useful for the study of the clinically important problem of multiple drug resistance in human cancer.


Jan 1, 1977·Methods in Cell Biology·R L Davidson, P S Gerald
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R J KaufmanR T Schimke
Mar 1, 1978·Somatic Cell Genetics·V Ling, R M Baker
Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Dec 14, 1976·Biochimica Et Biophysica Acta·S A CarlsenV Ling
Jan 9, 1976·Science·W A Nelson-Rees, R R Flandermeyer
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N RichertI Pastan
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
Feb 1, 1974·Journal of Cellular Physiology·V Ling, L H Thompson
Aug 1, 1982·Molecular and Cellular Biology·P G DebenhamV Ling
Aug 1, 1983·European Journal of Cancer & Clinical Oncology·J M SiegfriedA C Sartorelli
Jan 1, 1981·Cold Spring Harbor Symposia on Quantitative Biology·R T SchimkeD L Slate

❮ Previous
Next ❯


Feb 1, 1997·Journal of Clinical Pharmacology·R M LushW D Figg
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·G F FlemingA R Safa
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·I AbrahamK E Sampson
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·S IshiiT Tsuruo
Jan 11, 1991·Cancer Chemotherapy and Pharmacology·J E GervasoniJ Lutzky
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·P J HoughtonG B Grindey
Jan 1, 1993·Cytotechnology·U A Germann
Jan 1, 1993·Cytotechnology·P V Schoenlein
Jan 1, 1993·Cytotechnology·Y Heike, T Tsuruo
Jan 1, 1993·Cytotechnology·G Belvedere, E Dolfini
Aug 1, 1990·Journal of Bioenergetics and Biomembranes·S E KaneM M Gottesman
Feb 1, 1997·Virchows Archiv : an International Journal of Pathology·Y OdaA Roessner
Sep 1, 1991·Somatic Cell and Molecular Genetics·M T HasanT Y Chang
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·J HofmannH Grunicke
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·Y OdaA Roessner
Jul 1, 1986·Somatic Cell and Molecular Genetics·A FojoI Pastan
May 1, 1986·Somatic Cell and Molecular Genetics·W G ChaneyP Stanley
Jan 1, 1993·Cancer Immunology, Immunotherapy : CII·A S ChongJ S Coon
Jan 1, 1987·Breast Cancer Research and Treatment·A FojoI Pastan
Nov 1, 1994·Somatic Cell and Molecular Genetics·L A HanchettB J Dolnick
Oct 16, 2008·In Vitro Cellular & Developmental Biology. Animal·I H Lelong-RebelG Rebel
Oct 1, 1991·Chemistry and Physics of Lipids·S Adam, F Kaufmann
Feb 1, 1988·Trends in Pharmacological Sciences·M M Gottesman, I Pastan
Oct 1, 1991·Human Immunology·J S CoonH M Gebel
Mar 23, 2004·Biochemical and Biophysical Research Communications·Joachim TroostJohanna Weiss
Jan 20, 2009·Biochemical Pharmacology·Ying ZhouZhe-Sheng Chen
Mar 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dong XuR L Juliano
May 30, 1997·European Journal of Pharmacology·K NanaumiT Tsuruo

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
N RichertI Pastan
Proceedings of the National Academy of Sciences of the United States of America
I B RoninsonI Pastan
Proceedings of the National Academy of Sciences of the United States of America
A FojoI Pastan
© 2021 Meta ULC. All rights reserved